Arthur D. LittleArthur D. Little

Publications / Reports

Impact of Digital Health on the Pharmaceutical Industry

Impact of Digital Health on the Pharmaceutical Industry

Will Business Models be Reshaped by Digital Health?

Digital Health will transform the business models of the Pharmaceutical industry. Although many companies have not yet formulated a concise Digital Health strategy, industry executives expect that by 2020, Digital Health will enable Pharmaceutical companies to activate new business segments as well as to significantly improve their competitive advantage. This is the result of a global survey conducted in the Pharmaceutical industry by Arthur D. Little and the Karlsruher Institute of Technology (KIT) to capture the current thinking and the expectations regarding the transformative impact of Digital Health.

Released: December 2013

Download File ADL_HC_2013_Digital-Health_final.pdf (.PDF, 883 Kb)

previous report | next report